← Back to headlines
Biogen Inc. Receives Upgrade from UBS Citing Upcoming Pipeline Catalysts
UBS has upgraded its rating for Biogen Inc., anticipating positive developments from the company's drug pipeline that could drive future growth.
27 Apr, 06:05 — 27 Apr, 06:05
Sources
Showing 1 of 1 sources
